This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Rosemary Harrison
CBO at Nabla Bio
Presenter

Profile

Rosemary Harrison is the Chief Business Officer at Nabla Bio. Nabla is building the world's most advanced AI platform for biologics discovery and development. The company uses de novo design and humanized, functional screening to rapidly develop antibodies, nanobodies, and other protein therapeutics against a wide range of challenging targets. Through our pharma partners, we have multiple AI-native therapeutics progressing towards the clinic.

Agenda Sessions

  • Antibodies: Nabla Bio

    17:15